Dr. Shaywitz focuses on transformational opportunities and implementation challenges presented by emerging technologies in the context of biopharmaceuticals, from NGS and cell therapies to digital biomarkers and the meaningful application of AI. A graduate of Harvard College and the MD/PhD program at Harvard/MIT, Dr. Shaywitz trained in medicine and endocrinology at MGH, and conducted post-doctoral research in the Melton Lab at Harvard. He subsequently worked at Merck, Boston Consulting Group, Theravance, and DNAnexus, a Silicon Valley cloud genomics company where he served as Chief Medical Officer. From 2017-2019, he was Senior Partner in the Palo Alto office of Takeda Ventures, Inc., serving on multiple boards. He recently founded "Astounding HealthTech," providing advisory services to biopharma leaders and digital/data startup founders. Dr. Shaywitz writes extensively about innovation and biopharma, and since 2015 has co-hosted the popular “Tech Tonics” podcast with Lisa Suennen. He is an adjunct scholar at the AEI.
Overcoming data mining and visualization challenges is critical to the success of data science. Converting data to a visual framework such as data clustering allows trend recognition which in turn can help with decision making. This approach to insight generation linked with human experience will be very powerful for all aspects of data sciences.